FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Monika Peeters

Research Profile

Chemicals & Drugs

Living Beings

HIV-1

Disorders

HIV Infections

Concepts & Ideas

Physiology

Procedures

Phenomena

HIV Seronegativity

Co-author Network

Publications

TOP 3
Christophe Moreno; Monika Peeters; Vanitha Sekar; Tawesak Tanwandee; Satawat Thongsawat; Hans Van Vlierberghe; Stefan Zeuzem; Thomas Berg; Oliver Lenz; Goedele de Smedt
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.
Monika Schöller-Gyüre; Thomas N Kakuda; Brian Woodfall; Fatima Aharchi; Monika Peeters; Kati Vandermeulen; Richard Hoetelmans
Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone.
Calvin J Cohen; Daniel S. Berger; Gary Blick; Howard A Grossman; Dushyantha Jayaweera; Peter Shalit; Melanie Thompson; Monika Peeters; Marie-Pierre de Bethune; Ellen Voorspoels; Rebecca Mack; Brian Woodfall
Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Monika Peeters (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Christophe Moreno; Monika Peeters; Vanitha Sekar; Tawesak Tanwandee; Satawat Thongsawat; Hans Van Vlierberghe; Stefan Zeuzem; Thomas Berg; Oliver Lenz; Goedele de Smedt
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.
Journal of hepatology 2012;56(6):1247-53.
2009: Monika Schöller-Gyüre; Thomas N Kakuda; Brian Woodfall; Fatima Aharchi; Monika Peeters; Kati Vandermeulen; Richard Hoetelmans
Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone.
Contraception 2009;80(1):44-52.
2009: Calvin J Cohen; Daniel S. Berger; Gary Blick; Howard A Grossman; Dushyantha Jayaweera; Peter Shalit; Melanie Thompson; Monika Peeters; Marie-Pierre de Bethune; Ellen Voorspoels; Rebecca Mack; Brian Woodfall
Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial.
AIDS (London, England) 2009;23(3):423-6.
2009: Keikawus Arastéh; Armin Rieger; Patrick Yeni; Anton Pozniak; Griet Boogaerts; Rolf van Heeswijk; Marie-Pierre de Bethune; Monika Peeters; Brian Woodfall
Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy.
Antiviral therapy 2009;14(5):713-22.
2008: Monika Schöller-Gyüre; Marta Boffito; Anton L Pozniak; Ruud Leemans; Thomas N Kakuda; Brian Woodfall; Veerle Vyncke; Monika Peeters; Kati Vandermeulen; Richard Hoetelmans
Effects of different meal compositions and fasted state on the oral bioavailability of etravirine.
Pharmacotherapy 2008;28(10):1215-22.
2008: Monika Schöller-Gyüre; Thomas N Kakuda; Goedele De Smedt; Hilde Vanaken; Marie-Paule Bouche; Monika Peeters; Brian Woodfall; Richard Hoetelmans
A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.
British journal of clinical pharmacology 2008;66(4):508-16.
2008: Monika Peeters; Katrien Janssen; Thomas N Kakuda; Monika Schöller-Gyüre; Ruth Lachaert; Richard Hoetelmans; Brian Woodfall; Goedele De Smedt
Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers.
The Annals of pharmacotherapy 2008;42(6):757-65.
2008: Monika Schöller-Gyüre; Wim van den Brink; Thomas N Kakuda; Brian Woodfall; Goedele de Smedt; Hilde Vanaken; Tanja Stevens; Monika Peeters; Kati Vandermeulen; Richard Hoetelmans
Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers.
Journal of clinical pharmacology 2008;48(3):322-9.
2007: Richard Hoetelmans; Kris Mariën; Martine De Pauw; Andrew Hill; Monika Peeters; Vanitha J Sekar; Piet De Doncker; Brian Woodfall; Eric Lefebvre
Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers.
British journal of clinical pharmacology 2007;64(5):655-61.
2007: Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christine Katlama; Arend Moll; William Towner; Benoit Trottier; Monika Peeters; Johan Vingerhoets; Goedele de Smedt; Benny Baeten; Greet Beets; Rekha Sinha; Brian Woodfall
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.
Lancet 2007;370(9581):39-48.
2007: Esper Kallas; Pedro Cahn; Beatriz Grinsztejn; Richard Haubrich; Jacob P Lalezari; Anthony Mills; Gilles Pialoux; Timothy Wilkin; Monika Peeters; Johan Vingerhoets; Goedele de Smedt; Lorant Leopold; Roberta Trefiglio; Brian Woodfall
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.
Lancet 2007;370(9581):29-38.
2007: Monika Schöller-Gyüre; Thomas N Kakuda; Vanitha J Sekar; Brian Woodfall; Goedele de Smedt; Eric Lefebvre; Monika Peeters; Richard Hoetelmans
Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers.
Antiviral therapy 2007;12(5):789-96.
2007: Vanitha J Sekar; Martine De Pauw; Kris Mariën; Monika Peeters; Eric Lefebvre; Richard Hoetelmans
Pharmacokinetic interaction between TMC114/r and efavirenz in healthy volunteers.
Antiviral therapy 2007;12(4):509-14.
2006: Frank-Detlef Goebel; Alexy Yakovlev; Anton L Pozniak; Elena Vinogradova; Griet Boogaerts; Richard Hoetelmans; Marie-Pierre de Bethune; Monika Peeters; Brian Woodfall
Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects.
AIDS (London, England) 2006;20(13):1721-6.
2003: Brian G Gazzard; Anton L Pozniak; Willy Rosenbaum; G Patrick Yeni; Schlomo Staszewski; Keikawus Arastéh; Karin De Dier; Monika Peeters; Brian Woodfall; Justin Stebbing; Gerben A vant' Klooster
An open-label assessment of TMC 125--a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance.
AIDS (London, England) 2003;17(18):F49-54.
2003: Sanjay U C Sankatsing; Gerrit Jan Weverling; Monika Peeters; Gerben van't Klooster; Boris Gruzdev; Aza Rakhmanova; Sven A Danner; Suzanne Jurriaans; Jan M Prins; Joep M A Lange
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.
AIDS (London, England) 2003;17(18):2623-7.
2003: Boris Gruzdev; Aza Rakhmanova; Ekaterina Doubovskaya; Alexy Yakovlev; Monika Peeters; Alex Rinehart; Karin de Dier; Patricia Baede-Van Dijk; Wim Parys; Gerben van 't Klooster
A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjects.
AIDS (London, England) 2003;17(17):2487-94.